Back to Authors

Stone, Lael A.

A5109981286 | I2802865341

Mayo Clinic

American Academy of Neurology

Citations 3

A safety and pharmacokinetic study of intravenous natalizumab in patients with MS

Neurology | May 13, 2012 | Volume: 52 | Issue: 5 | Pages: 1072-1072

10.1212/wnl.52.5.1072 | PMID 10102433

Characterization of MRI response to treatment with interferon beta-1b: Contrast-enhancing MRI lesion frequency as a primary outcome measure

Neurology | May 13, 2012 | Volume: 49 | Issue: 3 | Pages: 862-869

10.1212/wnl.49.3.862 | PMID 9305355

Interferon beta results in immediate reduction of contrast‐enhanced MRI lesions in multiple sclerosis patients followed by weekly MRI

Neurology | May 13, 2012 | Volume: 48 | Issue: 5 | Pages: 1446-1448

10.1212/wnl.48.5.1446 | PMID 9153489